Abstract
Aim
Validation of the recently published newer clinical scoring system for bladder pain syndrome/interstitial cystitis and comparison of the results with the pre-existing standard O’Leary–Sant score.
Introduction
The symptoms are our primary guide to disease severity analysis, treatment, and response monitoring. The combined ICSI/ICPI (O’Leary–Sant Interstitial Cystitis Symptom and Problem Index) consist of a four-item symptom and problem index focusing on urgency, frequency, nocturia, and pain. A new scale, assigning more weight to pain and nocturia and adding the domains of sexual dysfunction and psychological impact, has been published by one of the authors (El Khoudary et al. J Women's Health 2002. 18:1361-1368; 7).
Material and methods
This is a prospective study conducted to validate a newer clinical scoring system, namedht e ‘Apollo Clinical Scoring’ (ACS) system for patients with bladder pain syndrome/ interstitial cystitis (BPS/IC), and to compare its outcome with the simultaneously applied standard O’Leary–Sant (OLS) score. Thirty-five patients of BPS/IC diagnosed using the ESSIC definition were enrolled in the study and followed for 6 months. Intraclass correlation coefficient (ICC) for test–retest reliability, and Cronbach’s α for measure of internal consistency, were applied to both scoring systems.
Results
Intraclass correlation coefficient for ACS was 0.715 and for OLS was 0.689. Cronbach’s α for ACS was 0.736 and for OLS was 0.698.
Conclusion
The present study suggests that the recently devised Apollo Clinical Scoring (ACS) system for patients of BPS/IC is internally consistent and a reliable scoring system. When compared with OLS in parallel setting, the newer ACS appeared to be marginally better.
Similar content being viewed by others
References
Skene A. Diseases of the bladder and urethra in women (p. 167). New York: Wm Wood; 1887.
Van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60–7.
O’Leary MP, Sant GR, Fowler FJ Jr, Whitmore KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology. 1997;49(5A Suppl):58–63.
Keller ML, McCarthy DO, Neider RS. Measurement of symptoms of interstitial cystitis. A pilot study. Urol Clin North Am. 1994;21:67–71.
Parsons CL, Dell J, Stanford EJ, et al. Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology. 2002;60:573–8.
Humphrey L, Arbuckle R, Moldwin R, et al. The bladder pain/interstitial cystitis symptom score: development, validation, and identification of a cut score. Eur Urol. 2012;61:271–9.
El Khoudary SR, Talbott EO, Bromberger JT, Chang C-CH, Songer TJ, Davis EL. Severity of interstitial cystitis symptoms and quality of life in female patients. J Women's Health 2002. 2009;18(9):1361-1368. https://doi.org/10.1089/jwh.2008.1270.
Ginting JV, Tripp DA, Nickel JC, Fitzgerald MP, Mayer R. Spousal support decreases the negative impact of pain on mental quality of life in women with interstitial cystitis/painful bladder syndrome. BJU Int. 2011;108(5):713–7. https://doi.org/10.1111/j.1464-410X.2010.09846.x.
Tripp DA, Nickel JC, Wong J, et al. Mapping of pain phenotypes in female patients with bladder pain syndrome/interstitial cystitis and controls. Eur Urol. 2012;62(6):1188–94. https://doi.org/10.1016/j.eururo.2012.05.023.
Troxel WM, Booth M, Buysse DJ, et al. Sleep disturbances and nocturnal symptoms: relationships with quality of life in a population-based sample of women with interstitial cystitis/bladder pain syndrome. J Clin Sleep Med. 2014;10(12):1331–7. https://doi.org/10.5664/jcsm.4292.
Nickel JC, Tripp D, Teal V, et al. Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis. J Urol. 2007;177(5):1832–6. https://doi.org/10.1016/j.juro.2007.01.060.
Liu B, Su M, Zhan H, Yang F, Li W, Zhou X. Adding a sexual dysfunction domain to UPOINT system improves association with symptoms in women with interstitial cystitis and bladder pain syndrome. Urology. 2014;84(6):1308–13. https://doi.org/10.1016/j.urology.2014.08.018.
Gardella B, Porru D, Ferdeghini F, et al. Insight into urogynecologic features of women with interstitial cystitis/painful bladder syndrome. Eur Urol. 2008;54(5):1145–51. https://doi.org/10.1016/j.eururo.2008.01.079.
Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163(20):2433–45. https://doi.org/10.1001/archinte.163.20.2433.
Chung S-D, Huang C-C, Lin H-C. Chronic prostatitis and depressive disorder: a three year population-based study. J Affect Disord. 2011;134(1-3):404–9. https://doi.org/10.1016/j.jad.2011.05.046.
Grandi G, Xholli A, Ferrari S, Cannoletta M, Volpe A, Cagnacci A. Intermenstrual pelvic pain, quality of life and mood. Gynecol Obstet Investig. 2013;75(2):97–100. https://doi.org/10.1159/000343997.
Smorgick N, Marsh CA, As-Sanie S, Smith YR, Quint EH. Prevalence of pain syndromes, mood conditions, and asthma in adolescents and young women with endometriosis. J Pediatr Adolesc Gynecol. 2013;26(3):171–5. https://doi.org/10.1016/j.jpag.2012.12.006.
Clemens JQ, Brown SO, Calhoun EA. Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study. J Urol. 2008;180(4):1378–82. https://doi.org/10.1016/j.juro.2008.06.032.
Goldstein HB, Safaeian P, Garrod K, Finamore PS, Kellogg-Spadt S, Whitmore KE. Depression, abuse and its relationship to interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(12):1683–6. https://doi.org/10.1007/s00192-008-0712-x.
Keller JJ, Liu S-P, Lin H-C. Increased risk of depressive disorder following diagnosis with bladder pain syndrome/interstitial cystitis. Neurourol Urodyn. 2013;32(5):467–71. https://doi.org/10.1002/nau.22316.
Nickel JC, Shoskes D, Irvine-Bird K. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management. J Urol. 2009;182(1):155–60. https://doi.org/10.1016/j.juro.2009.02.122.
El Khoudary SR, Talbott EO, Bromberger JT, Chang C-CH, Songer TJ, Davis EL. Severity of interstitial cystitis symptoms and quality of life in female patients. J Womens Health (Larchmt). 2009;18(9):1361–8. https://doi.org/10.1089/jwh.2008.1270.
Taneja R, Massand S. A modified clinical scoring system for bladder pain syndrome: longterm experience. Int J Urol. 2019;26(Suppl. 1):61–7.
Taneja R. Intravesical lignocaine in the diagnosis of bladder pain syndrome. Int Urogynecol J. 2010;21(3):321–4. https://doi.org/10.1007/s00192-009-1045-0.
Taneja, R., Pandey, S., Priyadarshi, S, et al. Diagnostic and therapeutic cystoscopy in bladder pain syndrome/interstitial cystitis: systematic review of literature and consensus on methodology. Int Urogynecol J. 2023;34(6):1165–73. https://doi.org/10.1007/s00192-023-05449-w
Lubeck D P, Whitmore K, Sant G R, Alvarez-Horine S, Lai C. Psychometric validation of the O'Leary–Sant Interstitial Cystitis Symptom Index in a clinical trial of pentosan polysulfate sodium. Urology. 2001;57(6 Suppl 1):62–6.
Esen B, Obaid K, Suer E, Gokce MI, Gokmen D, Beduk Y, Gulpinar O. Reliability and validity of Turkish versions of the interstitial cystitis symptom index and interstitial cystitis problem index. Neurourol Urodyn. 2020;39(8):2338–43.
Marcella LV, D’Ancona CAL, Junqueira RC, Silva DC, Oliveira HC, Lopes MH. Test-retest reliability and discriminant validity for the Brazilian version of “The Interstitial Cystitis Symptom Index and Problem Index” and “Pelvic Pain and Urgency/Frequency (PUF) Patient Symptom Scale” instruments. Transl Androl Urol. 2015;4(6):594–9
Arlandis S, Franco A, Mora AM. Rebollo P validation of the Spanish version of the bladder pain/interstitial cystitis-symptom score (BPIC-SS) questionnaire. A useful tool for the diagnosis of bladder pain syndrome. Actus Urol Esp. 2018;42(7):457–64.
Author information
Authors and Affiliations
Contributions
Rajesh Taneja — concept, direction, guidance overall supervision.
Ashutosh Kumar Singh — collection of data and statistical analysis.
Ankur Sharma & Nilesh Taneja — tabulation of data, writing of manuscript draft.
Apeksha Raheja — draft corrections and final proof reading.
Corresponding author
Ethics declarations
Conflicts of interest
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Taneja, R., Singh, A.K., Sharma, A. et al. Validation study of new clinical scoring — “Apollo Clinical Scoring system” for bladder pain syndrome/interstitial cystitis and comparison of outcome with standard “O’Leary–Sant score”. Int Urogynecol J (2023). https://doi.org/10.1007/s00192-023-05641-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00192-023-05641-y